(Q61967073)
(Redirected from Q61967074)
Statements
A Double-Masked, Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 2 Study to Determine the Tolerability, Pharmacokinetics, and Pharmacodynamics of the GLP 1 Agonist HM11260C in Adult Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy (English)
0 references
December 2011
0 references
June 2013
0 references
72
0 references
18 year
0 references
65 year
0 references